首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   149060篇
  免费   47932篇
  国内免费   379篇
耳鼻咽喉   2289篇
儿科学   5684篇
妇产科学   1678篇
基础医学   27117篇
口腔科学   6736篇
临床医学   19508篇
内科学   38309篇
皮肤病学   8892篇
神经病学   21370篇
特种医学   5865篇
外科学   25582篇
综合类   441篇
一般理论   48篇
预防医学   7734篇
眼科学   2519篇
药学   10476篇
中国医学   1087篇
肿瘤学   12036篇
  2023年   544篇
  2022年   853篇
  2021年   2902篇
  2020年   5971篇
  2019年   12145篇
  2018年   11727篇
  2017年   12633篇
  2016年   13627篇
  2015年   13691篇
  2014年   14086篇
  2013年   15373篇
  2012年   9161篇
  2011年   9265篇
  2010年   11939篇
  2009年   8104篇
  2008年   6908篇
  2007年   5889篇
  2006年   5560篇
  2005年   5433篇
  2004年   4962篇
  2003年   4856篇
  2002年   4762篇
  2001年   1470篇
  2000年   1225篇
  1999年   986篇
  1998年   971篇
  1997年   765篇
  1996年   645篇
  1995年   553篇
  1994年   509篇
  1993年   421篇
  1992年   353篇
  1991年   337篇
  1990年   263篇
  1989年   248篇
  1988年   255篇
  1987年   193篇
  1986年   193篇
  1985年   224篇
  1984年   280篇
  1983年   240篇
  1982年   272篇
  1981年   224篇
  1980年   183篇
  1978年   182篇
  1977年   171篇
  1933年   178篇
  1932年   186篇
  1931年   173篇
  1930年   174篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
ObjectiveSpinal cord stimulation (SCS) is an effective treatment in failed back surgery syndrome (FBSS). We studied the effect of preimplantation opioid use on SCS outcome and the effect of SCS on opioid use during a two-year follow-up period.Materials and methodsThe study cohort included 211 consecutive FBSS patients who underwent an SCS trial from January 1997 to March 2014. Participants were divided into groups, which were as follows: 1) SCS trial only (n = 47), 2) successful SCS (implanted and in use throughout the two-year follow-up period, n = 131), and 3) unsuccessful SCS (implanted but later explanted or revised due to inadequate pain relief, n = 29). Patients who underwent explantation for other reasons (n = 4) were excluded. Opioid purchase data from January 1995 to March 2016 were retrieved from national registries.ResultsHigher preimplantation opioid doses associated with unsuccessful SCS (ROC: AUC = 0.66, p = 0.009), with 35 morphine milligram equivalents (MME)/day as the optimal cutoff value. All opioids were discontinued in 23% of patients with successful SCS, but in none of the patients with unsuccessful SCS (p = 0.004). Strong opioids were discontinued in 39% of patients with successful SCS, but in none of the patients with unsuccessful SCS (p = 0.04). Mean opioid dose escalated from 18 ± 4 MME/day to 36 ± 6 MME/day with successful SCS and from 22 ± 8 MME/day to 82 ± 21 MME/day with unsuccessful SCS (p < 0.001).ConclusionsHigher preimplantation opioid doses were associated with SCS failure, suggesting the need for opioid tapering before implantation. With continuous SCS therapy and no explantation or revision due to inadequate pain relief, 39% of FBSS patients discontinued strong opioids, and 23% discontinued all opioids. This indicates that SCS should be considered before detrimental dose escalation.  相似文献   
5.
6.

Background

Hyperglycaemia is common in patients with acute brain injury admitted to an intensive care unit (ICU). Many studies have found associations between development of hyperglycaemia and increased mortality in hospitalised patients. However, the optimal target for blood glucose control is unknown. We want to conduct a systematic review with meta-analysis and trial sequential analysis to explore the beneficial and harmful effects of restrictive versus liberal glucose control on patient outcomes in adults with severe acute brain injury.

Methods

We will systematically search medical databases including CENTRAL, Embase, MEDLINE and trial registries. We will search the following websites for ongoing or unpublished trials: http://www.controlled-trials.com/ , http://www.clinicaltrials.gov/ , www.eudraCT.com , http://centerwatch.com/ , The Cochrane Library's CENTRAL, PubMed, EMBASE, Science Citation Index Expanded and CINAHL. Two authors will independently review and select trials and extract data. We will include randomised trials comparing levels of glucose control in our analyses and observational studies will be included to address potential harms. The primary outcomes are defined as all-cause mortality, functional outcome and health-related quality of life. Secondary outcomes include serious adverse events including hypoglycaemia, length of ICU stay and duration of mechanical ventilation, and explorative outcomes including intracranial pressure and infection. Trial Sequential Analysis will be used to investigate the risk of type I error due to repetitive testing and to further explore imprecision. Quality of trials will be evaluated using the Cochrane Risk of Bias tool, and quality of evidence will be assessed using the Grading of Recommendations, Assessment, Development and Evaluations (GRADE) approach.

Discussion

The results of the systematic review will be disseminated through peer-reviewed publication. With the review, we hope to inform future randomised clinical trials and improve clinical practice.  相似文献   
7.
8.
We report a case of benign lymphoplasmacytic plaque (LPP) in a child. These asymptomatic erythematous papulonodular lesions are an emerging clinicopathological entity. Herein, we describe a previously unreported site for LPP lesions, namely, the volar wrist and the distal ipsilateral palm.  相似文献   
9.
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号